---
title: "SUPLET shareholders Shanghai United Semiconductor have completed their reduction period, with a total reduction of 3.166 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227350026.md"
description: "According to the Zhitong Finance APP, SUPLET announced that the shareholding reduction plan of its shareholder Shanghai Lianxin has expired, and it has reduced its holdings of the company's shares by a total of 3.166 million shares through centralized bidding trading"
datetime: "2025-02-06T10:04:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227350026.md)
  - [en](https://longbridge.com/en/news/227350026.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227350026.md)
generator: "portal-rs"
---

# SUPLET shareholders Shanghai United Semiconductor have completed their reduction period, with a total reduction of 3.166 million shares

According to the Zhitong Finance APP, SUPLET (300593.SZ) announced that the share reduction plan of its shareholder Shanghai Lianxin has expired, and it has reduced its holdings of the company's shares by a total of 3.166 million shares through centralized bidding transactions

### Related Stocks

- [300593.CN](https://longbridge.com/en/quote/300593.CN.md)

## Related News & Research

- [CPCA sees China August NEV retail sales at about 1.04 million, penetration may hit record](https://longbridge.com/en/news/296629445.md)
- [BYD debuts third-gen Tang SUV, launch set for Q4](https://longbridge.com/en/news/296577383.md)
- [VIMAB: Strong Q2 revenue growth and new battery contracts signal improving performance](https://longbridge.com/en/news/296577862.md)
- [09:02 ETYamaha and Steinberg Announce Major Updates for MGX, URX, CC1 and MixKey Ecosystem](https://longbridge.com/en/news/296496108.md)
- [11:26 ET540's AI & API Control Plane Now Awardable on the Department of War's Tradewinds Solutions Marketplace](https://longbridge.com/en/news/296635000.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**